BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 36057370)

  • 1. Single-cell RNA sequencing reveals intra-tumoral heterogeneity of glioblastoma and a pro-tumor subset of tumor-associated macrophages characterized by EZH2 overexpression.
    Chen X; Chen Y; Chen X; Wei P; Lin Y; Wu Z; Lin Z; Kang D; Ding C
    Biochim Biophys Acta Mol Basis Dis; 2022 Dec; 1868(12):166534. PubMed ID: 36057370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EZH2 suppression in glioblastoma shifts microglia toward M1 phenotype in tumor microenvironment.
    Yin Y; Qiu S; Li X; Huang B; Xu Y; Peng Y
    J Neuroinflammation; 2017 Nov; 14(1):220. PubMed ID: 29132376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Heterogeneity of Tumour-Associated Macrophages Contributes to the Recurrence and Outcomes of Glioblastoma Patients.
    Xuan Z; Fang L; Zhang G; Zhang X; Jiang J; Wang K; Huang P
    J Mol Neurosci; 2023 Jan; 73(1):1-14. PubMed ID: 36542317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissecting the role of novel EZH2 inhibitors in primary glioblastoma cell cultures: effects on proliferation, epithelial-mesenchymal transition, migration, and on the pro-inflammatory phenotype.
    Stazi G; Taglieri L; Nicolai A; Romanelli A; Fioravanti R; Morrone S; Sabatino M; Ragno R; Taurone S; Nebbioso M; Carletti R; Artico M; Valente S; Scarpa S; Mai A
    Clin Epigenetics; 2019 Dec; 11(1):173. PubMed ID: 31791385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. n-Butylidenephthalide Regulated Tumor Stem Cell Genes EZH2/AXL and Reduced Its Migration and Invasion in Glioblastoma.
    Yen SY; Chuang HM; Huang MH; Lin SZ; Chiou TW; Harn HJ
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28208648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ribosomal S6 protein kinase 4 promotes resistance to EZH2 inhibitors in glioblastoma.
    Pang F; Zhang L; Li M; Yi X; Wang Y; Yang P; Wen B; Jiang J; Teng Y; Yang X; Chen L; Xu J; Wang L
    Cancer Gene Ther; 2023 Dec; 30(12):1636-1648. PubMed ID: 37726387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EZH2 regulates the malignancy of human glioblastoma cells via modulation of Twist mRNA stability.
    Zhai X; Li LS; Zhou YD; Ji WY; Chen H; Xiao H; Liang P
    Eur J Pharmacol; 2021 Aug; 904():174177. PubMed ID: 34015321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Enhancer of Zeste Homolog 2 (EZH2) Expression on Brain Glioma Cell Proliferation and Tumorigenesis.
    Cheng T; Xu Y
    Med Sci Monit; 2018 Oct; 24():7249-7255. PubMed ID: 30305602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polycomb complex mediated epigenetic reprogramming alters TGF-β signaling via a novel EZH2/miR-490/TGIF2 axis thereby inducing migration and EMT potential in glioblastomas.
    Vinchure OS; Sharma V; Tabasum S; Ghosh S; Singh RP; Sarkar C; Kulshreshtha R
    Int J Cancer; 2019 Sep; 145(5):1254-1269. PubMed ID: 31008529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of CCL2 by EZH2 affects tumor-associated macrophages polarization and infiltration in breast cancer.
    Wang YF; Yu L; Hu ZL; Fang YF; Shen YY; Song MF; Chen Y
    Cell Death Dis; 2022 Aug; 13(8):748. PubMed ID: 36038549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA AGAP2-AS1 exerts oncogenic properties in glioblastoma by epigenetically silencing TFPI2 through EZH2 and LSD1.
    Luo W; Li X; Song Z; Zhu X; Zhao S
    Aging (Albany NY); 2019 Jun; 11(11):3811-3823. PubMed ID: 31186379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combining single-cell sequencing and spatial transcriptome sequencing to identify exosome-related features of glioblastoma and constructing a prognostic model to identify BARD1 as a potential therapeutic target for GBM patients.
    Zhao S; Wang Q; Ni K; Zhang P; Liu Y; Xie J; Ji W; Cheng C; Zhou Q
    Front Immunol; 2023; 14():1263329. PubMed ID: 37727789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EZH2 is a negative prognostic factor and exhibits pro-oncogenic activity in glioblastoma.
    Zhang J; Chen L; Han L; Shi Z; Zhang J; Pu P; Kang C
    Cancer Lett; 2015 Jan; 356(2 Pt B):929-36. PubMed ID: 25444902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Etomidate inhibits tumor growth of glioblastoma by regulating M1 macrophage polarization.
    Gao C; Nie Y
    Metab Brain Dis; 2024 Apr; 39(4):569-576. PubMed ID: 38300392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glioblastoma-instructed microglia transition to heterogeneous phenotypic states with phagocytic and dendritic cell-like features in patient tumors and patient-derived orthotopic xenografts.
    Yabo YA; Moreno-Sanchez PM; Pires-Afonso Y; Kaoma T; Nosirov B; Scafidi A; Ermini L; Lipsa A; Oudin A; Kyriakis D; Grzyb K; Poovathingal SK; Poli A; Muller A; Toth R; Klink B; Berchem G; Berthold C; Hertel F; Mittelbronn M; Heiland DH; Skupin A; Nazarov PV; Niclou SP; Michelucci A; Golebiewska A
    Genome Med; 2024 Apr; 16(1):51. PubMed ID: 38566128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BACH1 as a potential target for immunotherapy in glioblastomas.
    Yuan F; Cong Z; Cai X; Zhu J; Yuan L; Wang Y; Tang C; Ma C
    Int Immunopharmacol; 2022 Feb; 103():108451. PubMed ID: 34923423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EZH2 is a potential prognostic predictor of glioma.
    Chen YN; Hou SQ; Jiang R; Sun JL; Cheng CD; Qian ZR
    J Cell Mol Med; 2021 Jan; 25(2):925-936. PubMed ID: 33277782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of tumorigenicity by microRNA-138 through inhibition of EZH2-CDK4/6-pRb-E2F1 signal loop in glioblastoma multiforme.
    Qiu S; Huang D; Yin D; Li F; Li X; Kung HF; Peng Y
    Biochim Biophys Acta; 2013 Oct; 1832(10):1697-707. PubMed ID: 23707559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-cell RNA sequencing reveals tumor heterogeneity, microenvironment, and drug-resistance mechanisms of recurrent glioblastoma.
    Wu H; Guo C; Wang C; Xu J; Zheng S; Duan J; Li Y; Bai H; Xu Q; Ning F; Wang F; Yang Q
    Cancer Sci; 2023 Jun; 114(6):2609-2621. PubMed ID: 36853018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The short isoform of MS4A7 is a novel player in glioblastoma microenvironment, M2 macrophage polarization, and tumor progression.
    Ni B; Huang G; Yang R; Wang Z; Song H; Li K; Zhang Y; Wu K; Shi G; Wang X; Shen J; Liu Y
    J Neuroinflammation; 2023 Mar; 20(1):80. PubMed ID: 36944954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.